Investor · South San Francisco, CA

Matthew A. Mcclure

Open Matthew in the network graph →

Filings

1

SEC Form D

Connections

26

co-filers

Capital

$92.2M

across filings

Active

Nov 2023

to Nov 2023

Most-connected co-filers (26)

James Scopa · San Diego, CA1 shared John Seaberg · Plymouth, MN1 shared Hernan A. Kazah · Grand Cayman, Cayman Islands1 shared Carole P. Nuechterlein · Harrisburg, PA1 shared Jack A. Nielsen · South San Francisco, CA1 shared Julian P. Symons · South San Francisco, CA1 shared Lucinda A. Quan · South San Francisco, CA1 shared Leonid Beigelman · South San Francisco, CA1 shared Lawrence M. Blatt · South San Francisco, CA1 shared Andrew Pollard · Vancouver, British Columbia, Canada1 shared Tony Wood · Vancouver, British Columbia, Canada1 shared Rich Cannon · Alpharetta, GA1 shared Orville R. Gordon · Alpharetta, GA1 shared Alice H. Vilma · New York, NY1 shared Bradley N. Rothman · New York, NY1 shared Carla A. Harris · New York, NY1 shared David C. Schwab · Palo Alto, CA1 shared Caoimhghin O'Donnell · Luxembourg, Luxembourg1 shared Andre Penha · Sao Paulo/SP, Guernsey1 shared Bridget Martell · Vancouver, British Columbia, Canada1 shared Lesley A. Calhoun · Boston, MA1 shared Bridget P. Martell · South San Francisco, CA1 shared Anindya Bose · Alpharetta, GA1 shared Larry Mohl · Alpharetta, GA1 shared

Recent filings (1)

Aligos Therapeutics, Inc.Nov 2023 · 31 co-filers$92.2M Aligos Therapeutics, Inc.Nov 2023 · 31 co-filers$92.2M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Matthew in the interactive graph →